Trends and factors of botanical dietary supplement use among US adults with COPD from 1999 to 2016.

Yanjie SunRongying WangWeiwei TangChao LiNan Huo

Published in: PloS one (2020)

The overall use of BDS decreased during 1999 through 2016 for US adults with COPD. The potential benefit of these supplemental medications use for clinical outcomes might exist for adult COPD patients.

Keyphrases

chronic obstructive pulmonary disease
lung function
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
cystic fibrosis
air pollution
human health